Outcomes of out‐of‐hospital treatment of impending tonic–clonic status epilepticus with diazepam nasal spray: A retrospective combined cohort analysis
Epilepsia · 2026-11 · 67 (11) · 5692-5702
DOI: 10.1002/epi.70423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, online erschienen am 19.08.2026. Verfasst von John M Stern und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Diazepam, Status Epilepticus, Anticonvulsants. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Neurelis, Inc., Neurelis.
Abstract (Originalsprache)
Objective
We assessed the timing, dosing, and effectiveness of diazepam nasal spray in a large dataset of seizures treated in the out‐of‐hospital setting, using as reference the International League Against Epilepsy criteria for tonic–clonic status epilepticus (SE) and its treatment.
Methods
We analyzed pooled data from two studies evaluating the use of diazepam nasal spray as acute treatment for seizures in the out‐of‐hospital setting, a phase 1/2a pharmacokinetics and safety study (patients aged 2–5 years) and a phase 3 long‐term safety study (patients aged 6–65 years). For this analysis, tonic–clonic SE episodes were defined as seizures lasting beyond time point t 1 (5 min). Responder analyses examined SE termination by time point t 2 (30 min after seizure start) and SE termination ≤20 min after dose administration. SE recurrence at ≤1, 12, and 24 h after SE termination was also assessed. Rate of SE episodes for which ≥2 doses of diazepam nasal spray were administered was a proxy for effectiveness. We also reported safety data.
Results
Of episodes with sufficient data for classification, a total of 402 episodes were categorized as tonic–clonic SE. The majority of tonic–clonic SE episodes terminated by t 2 (248 [61.7%]) and nearly half terminated within 20 min after dose administration (200 [49.8%]). SE recurrence after SE termination was low, with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
- Neurelis, San Diego, California, USA.
- Northeast Regional Epilepsy Group and Hackensack University Medical Center, Hackensack, New Jersey, USA.
- Departments of Pediatrics and Neurology, Hackensack Meridian School of Medicine, Nutley, New Jersey, USA.
- Department of Neurology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
- Department of Neurology, Phoenix Children's Hospital, Phoenix, Arizona, USA.
ORCID-Profile: John M Stern, Leock Y Ngo, Eric B Segal, Danielle A Becker, Randa G Jarrar, Tracy A Glauser, Jurriaan M Peters, Emilio Perucca, Evelyn K Shih, Enrique Carrazana, Adrian L Rabinowicz
Förderung
- Neurelis, Inc.
- Neurelis
Zitieren
APA
Stern, J. M., Ngo, L. Y., Segal, E. B., Becker, D. A., Jarrar, R. G., Glauser, T. A., Peters, J. M., Perucca, E., Shih, E. K., Carrazana, E., & Rabinowicz, A. L. (2026). Outcomes of out‐of‐hospital treatment of impending tonic–clonic status epilepticus with diazepam nasal spray: A retrospective combined cohort analysis. Epilepsia, 67(11), 5692-5702. https://doi.org/10.1002/epi.70423
Vancouver
Stern JM, Ngo LY, Segal EB, Becker DA, Jarrar RG, Glauser TA, et al. Outcomes of out‐of‐hospital treatment of impending tonic–clonic status epilepticus with diazepam nasal spray: A retrospective combined cohort analysis. Epilepsia. 2026;67(11):5692-5702. doi:10.1002/epi.70423
BibTeX
@article{Stern2026,
author = {Stern, John M and Ngo, Leock Y and Segal, Eric B and Becker, Danielle A and Jarrar, Randa G and Glauser, Tracy A and Peters, Jurriaan M and Perucca, Emilio and Shih, Evelyn K and Carrazana, Enrique and Rabinowicz, Adrian L},
title = {Outcomes of out‐of‐hospital treatment of impending tonic–clonic status epilepticus with diazepam nasal spray: A retrospective combined cohort analysis},
journal = {Epilepsia},
year = {2026},
volume = {67},
number = {11},
pages = {5692--5702},
doi = {10.1002/epi.70423}
}
EUVIMED